MAPT and Alzheimer disease: Previous research in human studies showed amyloid β (Aβ), phosphorylated tau and α-synuclein deposits in Alzheimer’s disease (AD), progressive supranuclear palsy (PSP) and Parkinson’s disease (PD) post-mortem retinas [5, 10, 12].